Advertisement

Topics

Aptima, Inc. Company Profile

11:22 EST 12th December 2018 | BioPortfolio

Aptima specializes in solving the problems of human performance in today’s complex sociotechnical systems . We are market leaders in the design of organizations, user-centered technology and training systems that make individuals and teams more effective. Aptima’s unique approach – human-centered engineering – couples the principles of social science with quantitative, computational methods. We have a ten-year track record of success in delivering quantifiable performance improvements at all levels of commercial, government and military organizations.By using its expertise in how humans operate in complex environments, Aptima also provides modeling and decision support for counter-terrorism and intelligence activities.

Location

12 Gill Street, Suite 1400
Woburn
Massachusetts
01801
United States of America

Contact

Phone: 781.935.3966
Fax: 781.935.4385
Email: aptima_info@aptima.com.


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [6 Associated PubMed Articles listed on BioPortfolio]

HPV genotyping and E6/E7 transcript assays for cervical lesion detection in an Asian screening population-Cobas and Aptima HPV tests.

High-risk human papillomavirus (hrHPV) detection and genotyping by Cobas HPV test has become an important technical platform in cervical cancer screening. It may be used as a co-test with cervical cyt...

Evaluating the aptima HIV-1 quant Dx, HCV quant Dx and HBV quant assays against the Abbott HIV-1, HCV and HBV RealTime assays.

Viral load measurement is routine for the management of patients infected with HIV, HCV or HBV, using sensitive, quantitative, nucleic acid amplification tests (NAATs). However, platforms are not equi...

Analytical performance of the Hologic Aptima HBV Quant Assay and the COBAS Ampliprep/COBAS TaqMan HBV test v2.0 for the quantification of HBV DNA in plasma samples.

Quantification of HBV DNA is used for initiating and monitoring antiviral treatment. Analytical test performance consequently impacts treatment decisions.

Performance of the Atlas rapid test for Chlamydia trachomatis and women's attitudes toward point-of-care testing.

This study compared performance of Atlas io® diagnostic platform, a point-of-care (POC) PCR assay for Chlamydia trachomatis (CT), to Aptima Combo 2, a standard of care laboratory-based nucleic acid a...

Evaluation of self-collected vaginal specimens for the detection of high-risk HPV infection and the prediction of high-grade cervical intraepithelial lesions in a high-burden, low-resource setting.

To compare the performance of self-collected vaginal (V) specimens with clinician-collected cervical (C) specimens for detection of high-risk human papillomavirus (hrHPV) and cervical disease using th...

Clinical Trials [5 Associated Clinical Trials listed on BioPortfolio]

Collection of Samples From HIV-1 Infected Individuals for Evaluation of the Aptima HIV-1 Assay

The objective is to obtain plasma samples from Human Immunodeficiency Virus Type 1 (HIV-1) infected individuals that have viral loads across the dynamic range of the Aptima HIV-1 assay. Th...

Clinical Evaluation of the APTIMA® HPV Assay and Comparison With the HR HC2® Test Using LBC ThinPrep® Specimens

To assess and compare the performance of the HR HPV HC2® test (Qiagen/Digene) and the APTIMA® HPV Assay (Hologic) using LBC Specimens (ThinPrep® Pap Test) for the detection of HPV infec...

Collection of Samples for the Clinical Evaluation of the Aptima HBV (Hepatitis B Virus) Quant (Quantification) Assay

This non-interventional clinical study will be conducted to prospectively collect serial plasma samples from subjects with chronic HBV infection who are initiating antiviral therapy. These...

Clinical Evaluation of the Aptima® Combo 2® Assay Using the Panther® System in Female Urine Samples

The objective of this study is to evaluate the performance characteristics of the AC2 assay on the Panther system using female urine specimens.

Collection of Plasma and Serum Samples From Individuals Initiating Sofosbuvir for Chronic Hepatitis C for Testing

This non-interventional clinical study will be conducted to prospectively collect serial plasma and serum samples from treatment naïve subjects with chronic HCV infection who are initiati...

Companies [2 Associated Companies listed on BioPortfolio]

Aptima, Inc.

Aptima specializes in solving the problems of human performance in today’s complex sociotechnical systems . We are market leaders in the design of organizations, user-centered technology and trainin...

Gen-Probe Life Sciences Ltd

Gen-Probe Incorporated (NASDAQ: GPRO) is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) used primarily to diagnose human ...

More Information about "Aptima, Inc." on BioPortfolio

We have published hundreds of Aptima, Inc. news stories on BioPortfolio along with dozens of Aptima, Inc. Clinical Trials and PubMed Articles about Aptima, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Aptima, Inc. Companies in our database. You can also find out about relevant Aptima, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record